Source: Annual Congress 2005 - Mechanisms of resolution of inflammation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Levy (Boston, United States of America). An update on anti-inflammatory endogenous mediators. Annual Congress 2005 - Mechanisms of resolution of inflammation

Member's Comments

No comment yet.

Related content which might interest you: Resolution of inflammation in airway diseases Source: Annual Congress 2005 - Mechanisms of resolution of inflammation Year: 2005 New anti-inflammatory activities of Alpha-1-Antitrypsin and their role in COPD Source: Annual Congress 2005 - Protease-antiprotease revisited Year: 2005 Role of anti-inflammatory treatments in complex chronic comorbidities Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 Endogenous lipid mediators in the resolution of airway inflammation Source: Eur Respir J 2007; 30: 980-992 Year: 2007 Chronic inflammation in asthma Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=126 Year: 2003 Exploitation of anti-inflammatory mechanisms for the treatment of severe asthma Source: Annual Congress 2005 - Mechanisms of resolution of inflammation Year: 2005 Pathology, inflammation and cytokines of severe asthma Source: Eur Respir Mon 2011; 51: 97-106 Year: 2011 Lipid mediators in severe asthma Source: Eur Respir Mon 2011; 51: 218-235 Year: 2011 Neutrophil airway influx by platelet-activating factor in asthma: role of adhesion molecules and LTB4 expression Source: Eur Respir J 2003; 22: 290-297 Year: 2003 Endogenous mediators of resolution Source: Annual Congress 2006 - Resolution of airway and tissue inflammation “ emerging concepts Year: 2006 Formoterol protects against platelet-activating factor-induced effects in asthma Source: Eur Respir J 2004; 23: 71-75 Year: 2004 IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation. Source: International Congress 2018 – Novel drug targets for asthma and COPD Year: 2018 Local application of FTY720 to the lung abrogates experimental asthma by altering myeloid dendritic cell function Source: Annual Congress 2006 - Towards understanding the pathogenesis of asthma Year: 2006 Macrolide effects on the prevention of COPD exacerbations Source: Eur Respir J 2012; 40: 485-494 Year: 2012 The clinical importance of measuring airway inflammation Source: Annual Congress 2005 - Are we ready for "inflammometry"? The role of eNO in asthma management Year: 2005 IL-10 and IL-1ra mediates OVA-induced Th2 airway allergic response at short and long-term Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 Anti-cytokine approaches should target bronchial hyperresponsiveness rather than inflammation – Pro Source: Annual Congress 2006 - Pro/Con: asthma is (not) an inflammatory disease Year: 2006 The verdict Source: Annual Congress 2006 - Pro/Con: asthma is (not) an inflammatory disease Year: 2006 Inhibitors of PDE4 delay eosinophil apoptosis Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population Year: 2005